Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?

Lindner Andrea K.; Klatte Tobias; Comperat Eva; Heidegger Isabel; Pichler Renate

首页> 外文期刊>Urologic oncology >Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?

【24h】

Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?

机译：在非肌肉侵入性膀胱癌中靶向BCG和免疫检查点的治疗理由：这是未来吗？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Urologic oncology》 |2019年第6期|共3页
作者
Lindner Andrea K.; Klatte Tobias; Comperat Eva; Heidegger Isabel; Pichler Renate;
展开▼
作者单位

Med Univ Innsbruck Dept Urol Innsbruck Austria;

Royal Bournemouth &

Christchurch Hosp Dept Urol Bournemouth Dorset England;

Sorbonne Univ Hosp Tenon Dept Pathol Paris France;

Med Univ Innsbruck Dept Urol Innsbruck Austria;

Med Univ Innsbruck Dept Urol Innsbruck Austria;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future? [J] . Lindner Andrea K., Klatte Tobias, Comperat Eva, Urologic oncology . 2019,第6期

机译：在非肌肉侵入性膀胱癌中靶向BCG和免疫检查点的治疗理由：这是未来吗？
2. Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation [J] . Robert L. Ferris, Heinz-Josef Lenz, Anna Maria Trotta, Cancer Treatment Reviews . 2018,第期

机译：靶向肿瘤细胞和免疫检查点受体的治疗抗体组合的理由：通过IgG1同种型免疫效应刺激利用先天和适应性免疫
3. Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation [J] . Robert L. Ferris, Heinz-Josef Lenz, Anna Maria Trotta, Cancer Treatment Reviews . 2018,第期

机译：靶向肿瘤细胞和免疫检查点受体的治疗性抗体组合的基本原理：通过IgG1同种型免疫效应刺激利用先天生素和适应性免疫
4. A mathematical cancer model with BCG immunotherapy combined with immune checkpoints inhibitors: An optimal control approach [C] . Evren Hincal, Farouk Tijjani Saad, Isa Abdullahi Baba International Conference on Analysis and Applied Mathematics . 2018

机译：具有BCG免疫疗法的数学癌模型与免疫检查点抑制剂相结合：最佳控制方法
5. Targeting IgV-like Domain Immune Checkpoint Receptors with Novel Nucleic Acid and Protein-based Therapeutics [D] . Prodeus, Aaron. 2018

机译：用新型核酸和基于蛋白质的治疗药物靶向IgV样域免疫检查点受体
6. Dynamics of Immune Checkpoints Immune System and BCG in the Treatment of Superficial Bladder Cancer [O] . Farouk Tijjani Saad, Evren Hincal, Bilgen Kaymakamzade 2017

机译：免疫检查点免疫系统和卡介苗在浅表性膀胱癌治疗中的动力学
7. Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets [O] . Hwei-Fang Tsai, Ping-Ning Hsu 2017

机译：靶向免疫检查点的癌症免疫疗法：癌症免疫和新治疗靶标中T细胞功能障碍的机制

Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?

著录项

相似文献

相关主题

期刊订阅